By Fineline Cube China-based Acotec Scientific Holdings Ltd (HKG: 6669) has announced receiving market approvals from the National Medical Products Administration (NMPA) for its products YAN and P-Conic balloon. These approvals mark significant milestones in the company’s product development and market expansion efforts.
Product Details and Applications
YAN is a product designed to expand the coronary artery or coronary artery bypass stenosis to improve myocardial perfusion. It is also applicable to the expansion of coronary artery occlusive lesions to restore coronary artery blood flow in patients with ST-segment elevation myocardial infarction (STEMI). The P-Conic balloon, on the other hand, is a kind of percutaneous transluminal angioplasty (PTA) balloon designed for lower limb artery expansion. Its tapered balloon and high-pressure design allow for optimal vascular preparation.
Future Prospects and Strategic Implications
The market approvals for YAN and P-Conic balloon position Acotec Scientific Holdings to further enhance its presence in the medical device market. By introducing these innovative products, the company aims to address significant unmet medical needs and improve patient outcomes in cardiovascular care.-Fineline Info & Tech